Clostridium difficile infections elevate the risks for colectomy, mortality and postoperative complications after a colectomy for patients with ulcerative colitis, according to NEJM Journal Watch.

In a study of over 800 patients with biologic-naive ulcerative colitis, starting treatment with the α4β7 integrin receptor antagonist vedolizumab didn't hold a significantly higher risk for developing ...

Background: Recent reports suggest that Clostridium difficile colitis may be evolving into a more severe disease. During the second half of 2002 we noted an increase in the number of patients with ...

Four patients with severe disease were cured after receiving the new broad-spectrum antibiotic tigecycline. When patients with Clostridium difficile colitis do not respond to usual treatment with ...

Please provide your email address to receive an email when new articles are posted on . More patients in the bezlotoxumab group experienced recurrence vs. the placebo group (13% vs. 3%). Steroid use ...

TORONTO – Stool transplants appear to be a veritable home run in the treatment of recurrent C. difficile infections. Researchers are now questioning whether the therapy would work for a range of other ...

Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...

ATLANTA -- Mortality rates from Clostridioides difficile-related infections have fallen steadily since 2016, but the condition continues to take an uneven lethal toll based on sex, demographics, and ...

Lymphocytic and collagenous colitis are forms of microscopic colitis that can be caused by drugs. After re-exposure to a causative medication, such as entacapone, recurrence can be more acute and ...

TUESDAY, August 5, 2025 (HealthDay News) — C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most ...